OPT Opthea Limited

13.12
-0.09  -1%
Previous Close 13.2
Open 13.05
52 Week Low 10.22
52 Week High 13.9999
Market Cap $553,558,195
Shares 42,208,021
Float 42,208,021
Enterprise Value $520,679,946
Volume 6,273
Av. Daily Volume 0
Stock charts supplied by TradingView

Upcoming Catalysts

Drug Stage Catalyst Date
OPT-302
Diabetic macular edema
Phase 1/2
Phase 1/2
Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 14-day FREE TRIAL.
OPT-302
Wet age-related macular degeneration (AMD)
Phase 3
Phase 3
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien.